ACTIVITY IN 2013

(Unaudited data)



CUMULATIVE ACTIVITY AS OF THE END OF DECEMBER 2013



thousands of euros
2012
2013
Variation at current exchange rates
Variation at constant exchange rates


France
325,900
346,965
+ 6.5%
+ 6.5%


International :
240,394
270,766
+ 12.6%
+ 15.2%


Incl. Europe excluding France
184,489
204,283
+ 10.7%
+ 12.8%


Incl. North America
45,345
53,364
+ 17.7%
+ 22.2%


Incl. Other countries
10,560
13,119
+ 24.2%
+ 27.9%


Group Total
566,294
617,731
+ 9.1%
+ 10.2%







thousands of euros
2012
2013
Variation at current exchange rates
Variation at constant exchange rates


Non-proprietary Homeopathic Medicines
292,025
305,739
+ 4.7%
+ 4.9%


OTC Specialties
273,776
311,581
+ 13.8%
+ 15.8%


Other
493
411
- 16.6%
- 21.5%


Group Total
566,294
617,731
+ 9.1%
+ 10.2%



QUARTERLY ACTIVITY IN 2013 (variation at current rate)



 
1st Quarter
2nd Quarter
3rd Quarter
4th Quarter


thousands of euros
2012
2013
Var.

13/12
2012
2013
Var.

13/12
2012
2013
Var.

13/12
2012
2013
Var.

13/12


France
74,188
84,270
+ 13.6%
71,210
75,327
+ 5.8%
88,028
92,596
+ 5.2%
92,474
94,772
+ 2.5%


International :
54,904
73,751
+ 34.3%
41,216
42,436
+ 3.0%
69,839
76,890
+ 10.1%
74,435
77,689
+ 4.4%


Incl. Europe excluding France
41,807
54,334
+ 30.0%
28,889
29,047
+ 0.5%
55,345
61,256
+ 10.7%
58,448
59,646
+ 2.0%


Incl. North America
10,285
15,562
+ 51.3%
9,861
10,017
+ 1.6%
11,136
12,153
+ 9.1%
14,063
15,632
+ 11.2%


Incl. Other countries
2,812
3,855
+ 37.1%
2,466
3,372
+ 36.7%
3,358
3,481
+ 3.7%
1,924
2,411
+ 25.3%


Group Total
129,092
158,021
+ 22.4%
112,426
117,763
+ 4.7%
157,867
169,486
+ 7.4%
166,909
172,461
+ 3.3%







 
1st Quarter
2nd Quarter
3rd Quarter
4th Quarter


thousands of euros
2012
2013
Var.

13/12
2012
2013
Var.

13/12
2012
2013
Var.

13/12
2012
2013
Var.

13/12


Non-proprietary Homeopathic Medicines
73,427
79,062
+ 7.7%
70,206
73,035
+ 4.0%
69,959
73,597
+ 5.2%
78,433
80,045
+ 2.1%


OTC Specialties
55,576
78,866
+ 41.9%
42,007
44,600
+ 6.2%
87,811
95,813
+ 9.1%
88,382
92,302
+ 4.4%


Other
89
93
+ 4.5%
213
128
- 39.9%
97
76
- 21.6%
94
114
+ 21.3%


Group Total
129,092
158,021
+ 22.4%
112,426
117,763
+ 4.7%
157,867
169,486
+ 7.4%
166,909
172,461
+ 3.3%




HIGHLIGHTS OF THE FOURTH QUARTER



Sales revenue in the fourth quarter of 2013 grew by 3.3% (5% at current rate) particularly in favour of winter specialties in France, the United States and Spain.

Given the business increase and the control of the costs, the 2013 operating income will grow very significantly in comparison to 2012.



On December 31, 2013, the group's net cash position is close to 160 million euros.

In the United States, the settlement agreement aimed to put an end to the class action proceeding in California about the Children's Coldcalm® medicine obtained final approval from the Los Angeles Court on November 6, 2013. Since no appeal has been filed, this settlement has come into force.

A provision of one million US dollars was recorded for this litigation in 2011 covering all the costs relating to this settlement.


 


MEETING OF THE CENTRAL WORKS COUNCIL


On January 24, 2014, the Central Works Council of Boiron SA met within the frame of an information-consultation procedure. The General Management announced its intention to:



Merge the two distribution facilities located in the Lyon area on the site of Francheville. This merger should not lead to job losses.
Reorganize the IT department of Boiron SA. This project, which might have social consequences, could involve around fifty jobs until 2018.

 


Our next update: March 19, 2014, after the close of the stock market, publication of 2013 results.

Financial information manager: Philippe MONTANT

Contact for financial information: Véronique BOUSCAYROL

Investor relations: +33 (0) 4.78.45.63.43 - e-mail: finances@boiron.fr

ISIN Code: FR0000061129 (BOI) - Bloomberg: BOI FP - Reuters: BOIR.PA

The group's financial information is online at : www.boiron.com

Information réglementée
Communiqués au titre de l'obligation d'information permanente :

- Communiqué sur comptes, résultats, chiffres d'affaires
Communiqué intégral et original au format PDF :


http://www.actusnews.com/documents_communiques/ACTUS-0-34689-cp-boiron_240114.pdf

© Copyright Actusnews Wire

Recevez gratuitement par email les prochains communiqués de la société en vous inscrivant sur www.actusnews.com

Receive by email the next press releases of the company by registering on www.actusnews.com, it's free



Quelle: Actusnews